All muscular dystrophy patients are potentially at risk for developing cardiomyopathy or heart muscle disease. This can result in heart failure and progressive symptoms such as swelling or shortness of breath. In addition, the electrical system of the heart can be abnormal in some patients.
Based on the cardiac findings, therapy would be started to treat the cardiac disease and associated symptoms. This typically would include oral medications.
In advanced cases, consideration of a pacemaker and/or an implantable cardioverter defibrillator (ICD) may be discussed.
For patients with advanced heart failure, we offer a comprehensive support program that includes left ventricular assist devices (LVADs) and total artificial heart (TAH) technology.